Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04706052 |
|
Recruitment Status :
Completed
First Posted : January 12, 2021
Last Update Posted : January 13, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Facial Nerve Injuries Adenoma, Pleomorphic | Other: Superficial Parotidectomy |
| Study Type : | Observational |
| Actual Enrollment : | 101 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Retrospective |
| Official Title: | Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor: an Experience From a Low Resource Country |
| Actual Study Start Date : | January 2012 |
| Actual Primary Completion Date : | August 2020 |
| Actual Study Completion Date : | January 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Superficial Parotidectomy Patient
All the patients with pleomorphic adenoma irrespective of age and gender who underwent Superficial parotidectomy
|
Other: Superficial Parotidectomy
Classical procedure for pleomorphic adenoma of the parotid gland is superficial parotidectomy around the world. This study only observed the outcome with reference to facial nerve morbidity |
- incidence of temporary or permanent facial nerve injury [ Time Frame: 12 months ]Temporary facial nerve injury was defined as a feature of facial nerve palsy with full recovery to regular activity within six months. Permanent facial nerve injury was defined as any facial nerve dysfunction lasting beyond six months of operation.
- wound infection [ Time Frame: 12 months ]Rate of postoperative surgical site infection will be calculated
- seroma [ Time Frame: 12 months ]Rate of postoperative formation of seroma (non-infected collection) occurring after superficial parotidectomy will be calculated
- hematoma [ Time Frame: 12 months ]Rate of postoperative incidence of hematoma/ clot formation at the operative site will be calculated
- Frey's syndrome [ Time Frame: 12 months ]Frey's syndrome is the result of misdirected regeneration of parasympathetic fibres connecting with regenerating sympathetic nerve leading to facial sweating and flushing during times of eating food. Rate of occurrence of Frey's syndrome will be calculated to understand its incidence.
- salivary fistula [ Time Frame: 12 months ]Salivary fistula is abnormal communication between skin and remaining gland. Its rate of occurrence will be calculated during postoperative period after superficial parotidectomy.
- disfigured scar [ Time Frame: 12 months ]The number of participants developing cosmetically bad scar will be notified and data calculated.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All the patients with pleomorphic adenoma irrespective of age and gender were included
Exclusion Criteria:
- Patients with recurrent disease or unwilling for participation were excluded
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04706052
| Pakistan | |
| Fazila Hashmi | |
| Jāmshoro, Sindh, Pakistan | |
| Principal Investigator: | Fazila Hashmi, FCPS | Liaquat University of Medical and Health Sciences Jamshoro Pakistan |
| Responsible Party: | Fazila Hashmi, Assistant Professor, Liaquat University of Medical & Health Sciences |
| ClinicalTrials.gov Identifier: | NCT04706052 |
| Other Study ID Numbers: |
LUMHS/REC/-12 |
| First Posted: | January 12, 2021 Key Record Dates |
| Last Update Posted: | January 13, 2021 |
| Last Verified: | January 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Superficial Parotidectomy Facial Nerve Injuries Adenoma, Pleomorphic |
|
Adenoma Adenoma, Pleomorphic Facial Nerve Injuries Facies Disease Attributes Pathologic Processes Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Facial Nerve Diseases |
Mouth Diseases Stomatognathic Diseases Cranial Nerve Injuries Cranial Nerve Diseases Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries Neoplasms, Complex and Mixed |

